Individualizing Medicine 2014: From Promise to Practice focuses on how to translate the promise of genomic medicine to your practice. Expert speakers, focused breakout sessions, real-life case studies and a poster session provide opportunities to discover and discuss emerging topics in applied genomics.
This conference is intended for those who are interested in learning about the latest findings in genomics and how to apply them to your practice, to network with professionals in your field and to share your clinical case studies and research.
The goals Individualizing Medicine Conference are to explain practical applications for integrating genomics and pharmacogenomics to individualize patient care, discuss strategies to overcome obstacles of implementing genomic sequencing for patient care and to discuss how to disseminate genomic information to patients through an ethical, legal and regulatory framework. This will be accomplished by using cases, apply knowledge learned to discern whether a patient may benefit from whole-genome or whole-exome sequencing
Combined Meeting of the O'Leary Meeting and Minnesota Dermatologic Society Meeting - There will be workshops, lectures and general assembly, including a Minnesota Dermatologic Case review with patients.
This symposium will consist of a multi-media approach to updating physicians about the current and future care of dermatology patients with both common and rare diseases. Topics presented will include areas of clinical, laboratory, surgical, and pediatric dermatology. The information presented will be relevant to dermatopathologists, surgical dermatologists, general dermatologists, and pediatric dermatologists.
This course presents biological models of addictive disorders and evidence-based treatments of addictions. Topics incorporate new research on the biological basis for genomic subtypes of addiction. Emphasis is on the translation of basic science to the clinic, strategies for pharmacotherapy, incorporating a biologic framework of addiction into addiction psychoeducation and programming, and individualized approaches to the treatment of addictions with comorbid psychiatric diagnoses. Outcomes-based research using clinical electronic databases to enhance follow-up are also discussed as well as the bioethics guiding the assessment and treatment of addiction as an illness.
Want to learn about the latest findings in genomics and how to apply them to your practice? Network with professionals in your field? Share your clinical case studies and research?
Do this and more by attending the second annual IM conference, sponsored by the Mayo Clinic Center for Individualized Medicine. As new discoveries in individualized medicine make their way into practice, they present new challenges.
This conference addresses practical issues of integrating pharmacogenomics, microbiomics, epigenomics, and genomic medicine into patient care. Conference topics include the integration of drug-gene pair alerts into the EMR; understanding which patients might benefit from whole genome/exome sequencing interpretation and its relevance to prognosis and diagnosis; sharing complicated genomic information with patients; and discussion of regulatory, legal, and bioethical issues.
A pre-conference course, Omics 101, explores principles and applications of genomics and pharmacogenomics in clinical and laboratory practice.
Learn more, see speakers and detailed schedule at http://individualizingmedicineconference.mayo.edu
This course focuses on the core competencies for effective leadership in ethics committees and ethics consultation services. These will be illustrated and discussed through several practical ethical issues arising out of community practice and caring for patients in the advanced stages of disease. These ethical dilemmas can be particularly challenging to the health care team and require attending to the many dimensions of care, including medical, psychosocial, ethical and spiritual needs. This course addresses managing the care transition from disease focus to symptom focus in end-of-life care; how to effectively determine patient preferences and reasonable and appropriate goals of care given underlying disease and management of inherent uncertainty; advocating for a coordinated, consistent approach to ethical dilemmas to reduce their frequency of occurrence and stress among families, their providers and the community; and critical elements of effective communication during ethical dilemmas at the end of life.